Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Home Health Care Services Quarterly|February 23, 2019
The subjective world of home care workers in dementia: an "order of worth" analysisJustine Schneider, Kristian Pollock, Samantha Wilkinson, et al.
BMC Medicine|September 15, 2021
The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapySreeram Ramagopalan, Thomas P Leahy, Joshua Ray, et al.
BMJ Quality & Safety|October 10, 2018
National hospital mortality surveillance system: a descriptive analysisElizabeth Cecil, Samantha Wilkinson, Alex Bottle, et al.
BMJ Quality & Safety|May 6, 2018
Investigating the association of alerts from a national mortality surveillance system with subsequent hospital mortality in England: an interrupted time series analysisElizabeth Cecil, Alex Bottle, Aneez Esmail, et al.
Clinical Epidemiology|December 15, 2017
Validation of asthma recording in electronic health records: a systematic reviewFrancis Nissen, Jennifer K Quint, Samantha Wilkinson, et al.
BMJ Open|May 31, 2017
Validation of asthma recording in electronic health records: protocol for a systematic reviewFrancis Nissen, Jennifer K Quint, Samantha Wilkinson, et al.
BMJ Open|July 30, 2018
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017Samantha Wilkinson, Ian Douglas, Heide Stirnadel-Farrant, et al.
Diabetes, Obesity & Metabolism|January 21, 2020
Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary careSamantha Wilkinson, Elizabeth Williamson, Ana Pokrajac, et al.
Clinical Epidemiology|December 7, 2018
Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary careSamantha Wilkinson, Ian J Douglas, Elizabeth Williamson, et al.
JAMA Network Open|October 7, 2021
Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world DataSamantha Wilkinson, Alind Gupta, Nicolas Scheuer, et al.
Pageof 3